Literature DB >> 23891574

Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.

Ruben Casado-Arroyo1, Gian-Battista Chierchia, Giulio Conte, Moisés Levinstein, Juan Sieira, Moises Rodriguez-Mañero, Giacomo di Giovanni, Yannis Baltogiannis, Kristel Wauters, Carlo de Asmundis, Andrea Sarkozy, Pedro Brugada.   

Abstract

BACKGROUND: Phrenic nerve palsy (PNP) is the most frequently observed complication during cryoballoon ablation (CB; Arctic Front, Medtronic, MN) occurring in roughly 7%-9% of the cases. The new second-generation cryoballoon ablation Arctic Front Advance (CB-A) (Arctic Front) has recently been launched in the market.
OBJECTIVE: To evaluate the incidence of right PNP with the new CB-A in comparison with the first-generation balloon in a series of consecutive patients that underwent pulmonary vein isolation with this modality.
METHODS: The study was designed as an observational study with a prospective follow-up. In total, 121 consecutive patients were included: 80 patients with the CB (group 1) and 41 with the CB-A (group 2).
RESULTS: Mean procedural times, fluoroscopic times, and time to pulmonary vein isolation documented by real-time recordings were significantly lower in group 2 (P ≤ .05). The occurrence of PNP was significantly higher in group 2 (6.25% [5 of 80] in group 1 vs 19.5% [8 of 41] in group 2; P = .033). At 7 months, PNP persisted in 1 (2.5%) patient in the CB-A group.
CONCLUSIONS: Right PNP seems to occur in a significantly larger number of patients with the second-generation CB-A. However, this complication is reversible in nearly all cases on short-term follow-up. More refined phrenic nerve monitoring during right-sided pulmonary vein ablation and less vigorous wedging maneuvers in the pulmonary vein ostia might significantly reduce the occurrence of this complication.
© 2013 Heart Rhythm Society. All rights reserved.

Entities:  

Keywords:  AAD; AF; Ablation; Atrial fibrillation; CB; CB-A; Complication; Cryoballoon; EGD; PN; PNP; PV; PVI; Phrenic nerve paralysis; Pulmonary vein isolation; RIPV; RSPV; SVC; antiarrhythmic drug treatment; atrial fibrillation; cryoballoon ablation; cryoballoon ablation Arctic Front Advance; esohagogastroduodenoscopy; phrenic nerve; phrenic nerve palsy; pulmonary vein; pulmonary vein isolation; right inferior pulmonary vein; right superior pulmonary vein; superior vena cava

Mesh:

Year:  2013        PMID: 23891574     DOI: 10.1016/j.hrthm.2013.07.005

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  43 in total

1.  The novel human gene aprataxin is directly involved in DNA single-strand-break repair.

Authors:  P Mosesso; M Piane; F Palitti; G Pepe; S Penna; L Chessa
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

2.  Novel Interventional Strategies for the Treatment of Atrial Fibrillation.

Authors:  Konstantinos C Siontis; Hakan Oral
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

3.  Anatomical predictors for successful pulmonary vein isolation using balloon-based technologies in atrial fibrillation.

Authors:  Alexey Tsyganov; Jan Petru; Jan Skoda; Lucie Sediva; Pavel Hala; Jiri Weichet; Marek Janotka; Milan Chovanec; Petr Neuzil; Vivek Y Reddy
Journal:  J Interv Card Electrophysiol       Date:  2015-10-16       Impact factor: 1.900

4.  [Innovative techniques in atrial fibrillation therapy].

Authors:  A Metzner; E Wissner; T Fink; F Ouyang; K-H Kuck
Journal:  Herz       Date:  2015-02       Impact factor: 1.443

Review 5.  Recent Advances in Lesion Formation for Catheter Ablation of Atrial Fibrillation.

Authors:  Adam S Barnett; Tristram D Bahnson; Jonathan P Piccini
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

6.  Cryoballoon Ablation in Today's Practice: Can the Left Common Ostium Be Ablated and Injury to the Right Phrenic Nerve Avoided?

Authors:  Gian-Battista Chierchia; Saverio Iacopino; Carlo de Asmundis
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

7.  A long-term evaluation of cryoballoon ablation in 205 atrial fibrillation patients: a single center experience.

Authors:  Alexander Bohó; Silvia Mišíková; Peter Spurný; Erika Komanová; Michal Kerekanič; Marek Hudák; Branislav Stančák
Journal:  Wien Klin Wochenschr       Date:  2015-07-04       Impact factor: 1.704

8.  Efficacy, High Procedural Safety And Rapid Optimization Of Cryoballoon Atrial Fibrillation Ablation In The Hands Of A New Operator.

Authors:  Eberhard Scholz; Patrick Lugenbiel; Patrick A Schweizer; Panagiotis Xynogalos; Claudia Seyler; Edgar Zitron; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  J Atr Fibrillation       Date:  2016-02-29

9.  Long-Term Evolution of Patients Treated for Paroxysmal Atrial Fibrillation with First and Second Generation Cryoballoon Catheter Ablation with a Prospective Protocol Guided by Complete Bidirectional Left Atrium-Pulmonary Veins Disconnection after Adenosine as Main Target end Point to achieved. Seven Years Follow-up of Patients with a rough estimation profile of Low ALARMEc Score. A Single Center Report.

Authors:  Jesus M Paylos; Aracelis Morales; Luis Azcona; Marisol Paradela; Raquel Yagüe; Fernando Gómez-Guijarro; Lourdes Lacal; R N Clara Ferrero; Octavio Rodríguez
Journal:  J Atr Fibrillation       Date:  2016-04-30

10.  Long-term outcome after second-generation cryoballoon ablation for paroxysmal atrial fibrillation - a 3-years follow-up.

Authors:  Ken Takarada; Ingrid Overeinder; Carlo de Asmundis; Erwin Stroker; Giacomo Mugnai; Valentina de Regibus; Darragh Moran; Hugo Coutino-Moreno; Juan-Pablo Abugattas; Rajin Choudhury; Diego Ruggiero; Gaetano Paparella; Saverio Iacopino; Pedro Brugada; Gian-Battista Chierchia
Journal:  J Interv Card Electrophysiol       Date:  2017-03-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.